Codiak Biosciences

Exosomes
#AAV #Codiak Biosciences #Evox Therapeutics #Mergers and acquisitions #Preclinical development

Evox Therapeutics acquires exosome AAV technology from Codiak

Evox Therapeutics has purchased Codiak Biosciences engEx-AAV technology platform, including all intellectual property rights, and exclusive access to certain engineering and manufacturing rights. The technology enables active loading of adeno-associated virus (AAV) into exosomes followed by their release when the AAV-loaded exosomes are delivered into recipient cells. This has been… Read More

#Business & Investment #News